https://www.biopharm.org.tw
+886-2-2655-8135
services@biopharm.org.twMain Products
V-CHECK develops affordable and reliable in vitro diagnostic tools for early detection of women's diseases, focusing on endometriosis, which affects 10% of women of reproductive age globally. Traditional diagnosis involves invasive and costly procedures like transvaginal ultrasound, functional MRI, and laparoscopy, causing delays of 6-8 years in the U.S. V-CHECK introduced the Vido Care Endometriosis ELISA blood test for early in vitro detection and the Vido Care Endometriosis LFA, the world’s first non-invasive rapid test for pre-screening and post-treatment monitoring.
immunoassay design and development
Main pipelines: in vitro diagnostic tests for women's reproductive problems. Patforms: immunoassay development and manufacturing
Business Interests
Out-Licensing, Clinical Trial Collaboration, Distribution, Co-Development, Strategic Alliance
Contact Info
Vivian Yang
CEO
+886-928308180
vyang@vcheck-biomed.com